IS5062A - Medicinal preparations containing N-sulfonylindoline derivatives - Google Patents

Medicinal preparations containing N-sulfonylindoline derivatives

Info

Publication number
IS5062A
IS5062A IS5062A IS5062A IS5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A IS 5062 A IS5062 A IS 5062A
Authority
IS
Iceland
Prior art keywords
preparations containing
medicinal preparations
sulfonylindoline
derivatives
sulfonylindoline derivatives
Prior art date
Application number
IS5062A
Other languages
Icelandic (is)
Inventor
Gautier Jean-Claude
John Fuller Simon
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of IS5062A publication Critical patent/IS5062A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IS5062A 1996-12-05 1999-06-01 Medicinal preparations containing N-sulfonylindoline derivatives IS5062A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (en) 1996-12-05 1996-12-05 PHARMACEUTICAL COMPOSITIONS CONTAINING N-SULFONYL INDOLINE DERIVATIVES
PCT/FR1997/002210 WO1998024430A1 (en) 1996-12-05 1997-12-04 Pharmaceutical compositions containing n-sulphonyl indolin derivatives

Publications (1)

Publication Number Publication Date
IS5062A true IS5062A (en) 1999-06-01

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5062A IS5062A (en) 1996-12-05 1999-06-01 Medicinal preparations containing N-sulfonylindoline derivatives

Country Status (25)

Country Link
EP (1) EP0941090A1 (en)
JP (1) JP2000507618A (en)
KR (1) KR20000069308A (en)
CN (1) CN1239887A (en)
AR (1) AR009651A1 (en)
AU (1) AU716575B2 (en)
BR (1) BR9712406A (en)
CA (1) CA2273990A1 (en)
CO (1) CO4910129A1 (en)
DZ (1) DZ2362A1 (en)
EE (1) EE9900206A (en)
FR (1) FR2756736B1 (en)
HU (1) HUP0001386A3 (en)
ID (1) ID23373A (en)
IL (1) IL129936A0 (en)
IS (1) IS5062A (en)
MY (1) MY132819A (en)
NO (1) NO992724L (en)
NZ (1) NZ335750A (en)
RU (1) RU2174394C2 (en)
SK (1) SK75599A3 (en)
TR (1) TR199901702T2 (en)
WO (1) WO1998024430A1 (en)
YU (1) YU23099A (en)
ZA (1) ZA9710919B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (en) * 1998-11-16 2000-12-08 Sanofi Sa PROCESS FOR THE PREPARATION OF (2S) -1 - [(2R, 3S) -5-CHLORO-3- (2- CHLOROPHENYL) -1- (3,4-DIMETHOXY BENZENESULFONYL) -3-HYDROXY- 2,3-DIHYDRO- 1H-INDOLE-2-CARBONYL] PYRROLIDINE-2-CARBOXAMIDE, ITS SOLVATES AND / OR HYDRATES
DE19913692A1 (en) * 1999-03-25 2000-09-28 Basf Ag Mechanically stable pharmaceutical dosage forms containing liquid or semi-solid surface-active substances
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
WO2001034119A2 (en) 1999-11-12 2001-05-17 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
FR2805992A1 (en) * 2000-03-08 2001-09-14 Sanofi Synthelabo Oral administration of N-sulfonyl-indoline derivative to treat central nervous system, cardiovascular or gastric disorders, using polyethylene glycol, polysorbate and poloxamer as solubilizers for high bioavailability
DE10026698A1 (en) 2000-05-30 2001-12-06 Basf Ag Self-emulsifying active ingredient formulation and use of this formulation
ITMI20011338A1 (en) * 2001-06-26 2002-12-26 Farmatron Ltd ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (en) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Compositions of pharmaceutical actives containing diethylene glycol monoethyl ether or other alkyl derivatives
KR102139339B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound
KR102139338B1 (en) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 Cosmetic composition which has improved solubility comprising indole compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (en) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. WATER-FREE EMULSIONS AND USE THEREOF
FR2679903B1 (en) * 1991-08-02 1993-12-03 Elf Sanofi DERIVATIVES OF N-SULFONYL INDOLINE CARRYING AN AMIDIC FUNCTION, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING SAME.

Also Published As

Publication number Publication date
WO1998024430A1 (en) 1998-06-11
ID23373A (en) 2000-04-20
FR2756736A1 (en) 1998-06-12
NO992724D0 (en) 1999-06-04
RU2174394C2 (en) 2001-10-10
TR199901702T2 (en) 1999-09-21
CA2273990A1 (en) 1998-06-11
EP0941090A1 (en) 1999-09-15
BR9712406A (en) 1999-08-31
CN1239887A (en) 1999-12-29
AR009651A1 (en) 2000-04-26
DZ2362A1 (en) 2002-12-28
CO4910129A1 (en) 2000-04-24
SK75599A3 (en) 2000-08-14
IL129936A0 (en) 2000-02-29
AU5326298A (en) 1998-06-29
MY132819A (en) 2007-10-31
EE9900206A (en) 1999-12-15
NO992724L (en) 1999-06-04
NZ335750A (en) 2001-06-29
ZA9710919B (en) 1999-06-04
AU716575B2 (en) 2000-03-02
HUP0001386A2 (en) 2001-04-28
JP2000507618A (en) 2000-06-20
FR2756736B1 (en) 1999-03-05
YU23099A (en) 1999-11-22
KR20000069308A (en) 2000-11-25
HUP0001386A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE236617T1 (en) AEROSOL MEDICINAL FORMULATIONS
DE69518331D1 (en) ORAL PREPARATIONS
NO974618D0 (en) Pharmaceutical preparations for intranasal administration
ATE304351T1 (en) MEDICINAL PREPARATIONS CONTAINING CANNABINOIDS
DE69708327D1 (en) POWDER INHALATOR
DK0783302T3 (en) drugs
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
NO954486D0 (en) Pharmaceutical formulation basis
ATE367150T1 (en) DRUG
NO995251D0 (en) Procedure for administering halotherapy
DE59707298D1 (en) DESODORING PREPARATIONS
DE69700887D1 (en) Isoprene derivatives
ATE298576T1 (en) MEDICINAL PREPARATIONS
ID16781A (en) PHARMACEUTICAL FORMULATIONS
NO992724D0 (en) Pharmaceutical mixtures containing N-sulfonyl-indoline derivatives
DE69432149D1 (en) Oral preparations
DK0925273T3 (en) Pharmaceutical preparations containing 4-oxo-butanoic acids
ITMI941169A0 (en) PHARMACEUTICAL FORMULATIONS
ID18698A (en) PHARMACEUTICAL COMPOSITION
DK0826679T3 (en) Naphthyl compounds and preparations
EE03511B1 (en) Prolonged release pharmaceutical preparations containing misolastin
ATE237309T1 (en) MEDICINAL PREPARATIONS
EP1142589A4 (en) MEDICINAL PREPARATIONS
FI951155L (en) Pharmaceutical preparation
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION